Financial Performance - Total revenue for 2025 was CNY 347.27 million, a decrease of 26.24% compared to the previous year[3] - Net profit attributable to shareholders was CNY -44.97 million, a decline of 311.22% year-on-year[3] - The company reported a net profit of CNY -65.90 million after deducting non-recurring gains and losses, a decrease of 562.30% compared to the previous year[3] - Basic earnings per share were CNY -0.48, down 308.70% from CNY 0.23 in the previous year[3] Assets and Equity - Total assets at the end of the reporting period were CNY 1,290.87 million, a decrease of 5.27% from the beginning of the period[5] - Shareholders' equity attributable to the parent company was CNY 1,190.04 million, down 5.23% from the beginning of the period[5] Revenue Impact Factors - The decline in revenue was significantly impacted by the national centralized procurement policy, leading to a revenue drop of approximately CNY 46.50 million from the HPV product line[6] - The company is focusing on optimizing its business structure and expanding distribution channels, which has temporarily affected overall gross margins[6] Future Outlook - Increased operational costs due to ongoing product research and development efforts in the fields of digital pathology and tumor companion diagnostics are expected to support long-term sustainable growth[6] - Investors are advised to note that the financial data presented is preliminary and unaudited, with final figures to be confirmed in the audited annual report[8]

Financial Performance - The company achieved total operating revenue of 223.51 million yuan, a year-on-year increase of 8.48%[2] - Net profit attributable to shareholders of the parent company reached 13.15 million yuan, a significant increase of 203.86% compared to the previous year[2] - The total assets at the end of the reporting period were 1,564.45 million yuan, reflecting a growth of 1.64% from the beginning of the period[4] - The net profit attributable to shareholders of the parent company, excluding non-recurring gains and losses, was -0.915 million yuan, an improvement of 96.77% year-on-year[4] - The company’s basic earnings per share was 0.10 yuan, compared to -0.09 yuan in the previous year, marking a 207.03% increase[2] - The weighted average return on net assets increased by 1.84 percentage points to 0.93%[2] Operational Strategy - The company strengthened its production guarantee system to meet the increased demand from orthopedic artificial bone procurement[5] - The marketing strategy focused on regional market development and precise marketing, contributing to steady revenue growth[5] - The significant increase in operating profit and total profit was attributed to the recovery of long accounts receivable due to extended credit terms for distributors[7] Financial Data Disclaimer - Investors are advised to note that the financial data for 2025 is preliminary and unaudited, with final results to be confirmed in the annual report[8]

Financial Performance - Total revenue for 2025 was CNY 583.88 million, a decrease of 0.55% compared to the previous year[6] - Operating profit reached CNY 122.47 million, reflecting a year-on-year increase of 2.54%[6] - Net profit attributable to shareholders was CNY 103.81 million, showing a slight increase of 0.08% year-on-year[6] - Net profit attributable to shareholders after deducting non-recurring gains and losses was CNY 99.49 million, up 5.66% from the previous year[6] Assets and Equity - Total assets at the end of the reporting period were CNY 1,106.36 million, an increase of 9.89% from the beginning of the period[6] - Equity attributable to shareholders increased to CNY 889.67 million, a growth of 6.96% compared to the start of the period[6] Business Development - The company successfully bid for national grid projects with new products such as integrated terminals and power metering transformers[6] - The company expanded into new overseas markets, enhancing its domestic and international product and industry layout[6] - The company is committed to a development strategy focused on "quality first and technology-driven" while advancing a multi-industry and multi-product approach[6] Audit and Reporting - The financial data presented is preliminary and subject to final audit in the 2025 annual report[8]

Financial Performance - Total revenue for 2025 reached RMB 2,195,752,453.11, an increase of 26.52% compared to RMB 1,735,455,070.67 in the previous year[3] - Operating profit for 2025 was RMB 1,247,537,159.18, reflecting a growth of 20.39% from RMB 1,036,240,027.64 in the prior year[3] - Net profit attributable to shareholders of the parent company was RMB 1,108,573,341.77, up 25.59% from RMB 882,710,217.15 year-on-year[3] - Basic earnings per share increased to 3.84, a rise of 25.08% from 3.07 in the previous year[3] Assets and Equity - Total assets at the end of the reporting period were RMB 6,575,519,110.89, an increase of 11.87% from RMB 5,877,949,136.52 at the beginning of the period[4] - The company's equity attributable to shareholders of the parent company grew by 10.14% to RMB 6,022,034,171.64 from RMB 5,467,518,127.30[4] - The company increased its share capital by 40.53% during the reporting period due to the implementation of a capital reserve transfer to increase share capital[5] Strategic Focus - The company increased its investment in technology research and market expansion, leading to growth in laser cutting control systems and intelligent robotics[5] - The company is focused on optimizing product structure and enhancing operational efficiency through lean management[5] Reporting Accuracy - There are no significant uncertainties affecting the accuracy of the performance report[7]

证券代码：688510 证券简称：航亚科技 公告编号：2026-011 无锡航亚科技股份有限公司 2025 年度业绩快报公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 本公告所载无锡航亚科技股份有限公司（以下简称"公司"）2025年度主要财 务数据为初步核算数据，未经会计师事务所审计，具体数据以公司2025年年度的 定期报告为准，提请投资者注意投资风险。 一、2025 年度主要财务数据和指标 单位：人民币万元 | 项目 | 本报告期 | 上年同期 | 增减变动幅度（％） | | --- | --- | --- | --- | | 营业总收入 | 69,867.42 | 70,323.75 | -0.65 | | 营业利润 | 11,256.39 | 13,633.16 | -17.43 | | 利润总额 | 11,241.16 | 13,650.90 | -17.65 | | 归属于母公司所有者的 净利润 | 10,212.58 | 12,652.53 | -19.28 | | 归属于母公司所有者的 扣除非经常性损益 ...

Financial Performance - The total operating revenue for 2025 reached RMB 1,178.62 million, an increase of 4.50% compared to the previous year[3] - The net profit attributable to shareholders was RMB 373.12 million, reflecting a growth of 17.81% year-on-year[3] - The net profit excluding non-recurring gains and losses was RMB 341.93 million, up 23.21% from the previous year[3] - The total assets at the end of 2025 amounted to RMB 968.48 million, representing an increase of 11.26% from the beginning of the year[3] - The equity attributable to shareholders increased to RMB 447.52 million, a rise of 3.71% compared to the start of the year[3] - The basic earnings per share rose to RMB 0.76, an increase of 18.75% year-on-year[3] - The weighted average return on equity improved to 8.57%, up by 1.11 percentage points from the previous year[3] Market and Industry Trends - The company maintained stable growth in sales volume and revenue due to effective marketing strategies and increased market share among domestic brands[6] - The automotive industry in China saw a 10.20% increase in production and a 9.20% increase in sales for passenger vehicles in 2025[6] - The prices of raw materials from upstream steel and aluminum manufacturers decreased, contributing to stable profit margins despite increased sales volume[6]

Financial Performance - Total operating revenue for 2025 reached CNY 309,164,765.32, an increase of 11.58% compared to CNY 277,091,212.17 in the previous year[3] - Operating profit decreased by 57.70% to CNY 18,591,131.28 from CNY 43,955,562.57 year-on-year[3] - Total profit fell by 59.52% to CNY 17,554,079.00 from CNY 43,359,554.40 in the previous year[3] - Net profit attributable to shareholders of the parent company decreased by 69.80% to CNY 11,865,168.46 from CNY 39,283,401.38 year-on-year[3] - Net profit attributable to shareholders of the parent company after deducting non-recurring gains and losses dropped by 80.21% to CNY 4,855,687.46 from CNY 24,531,062.63[3] - Basic earnings per share decreased by 69.53% to CNY 0.10 from CNY 0.32 in the previous year[3] R&D Investment - The company increased its R&D investment and launched the Shanghai R&D center project to enhance core product competitiveness[6] - The decline in net profit was influenced by increased R&D expenses and the lack of scale in new business development[6][8] Assets and Equity - Total assets at the end of the reporting period were CNY 1,358,066,689.33, a slight increase of 0.26% from CNY 1,354,484,847.76 at the beginning of the period[3] - Shareholders' equity attributable to the parent company increased by 1.01% to CNY 1,184,019,145.32 from CNY 1,172,153,976.86[4]

Financial Performance - The company achieved total operating revenue of RMB 68,333.84 million, a year-on-year increase of 30.71%[3] - Operating profit was reported at RMB -4,224.17 million, a reduction in loss of 43.56% compared to the previous year[5] - Net profit attributable to the parent company was RMB -4,391.13 million, a reduction in loss of 42.32% year-on-year[5] - Basic earnings per share were reported at RMB -0.1048, showing an improvement from RMB -0.1794 in the previous year[3] Assets and Equity - The total assets at the end of the reporting period were RMB 167,561.56 million, an increase of 1.43% from the beginning of the period[5] - The equity attributable to the parent company decreased by 5.29% to RMB 142,973.11 million[5] Research and Development - The company maintained a high level of R&D investment to sustain core competitiveness amid ongoing patent litigation costs of approximately RMB 5,935.88 million[6] Market Expansion - The Wi-Fi 7 product series significantly contributed to revenue growth, indicating strong market competitiveness[7] - The company is expanding its market presence in low-altitude economy and industrial IoT sectors, leading to increased net profit levels[8] Financial Data Disclaimer - Investors are advised to note that the financial data is preliminary and subject to audit, with potential discrepancies in the final report[9]

Financial Performance - In 2025, the company achieved total operating revenue of RMB 2.328 billion, a year-on-year increase of 2.0%[5] - Operating profit decreased by 33.72% to RMB 266.34 million, while total profit fell by 34.13% to RMB 264.76 million[3] - Net profit attributable to shareholders of the parent company was RMB 250.73 million, down 31.61% compared to the previous year[3] Revenue Breakdown - The company’s overseas revenue reached RMB 840 million, a 17.9% increase, accounting for 36% of total revenue, up 5 percentage points from 2024[5] - Domestic revenue declined by 5.5% to RMB 1.47 billion, but showed a recovery with a 14.5% increase in Q4[6] - New industries contributed 48.5% of total revenue, growing by 8.8%, while low-temperature storage revenue decreased by 3.9%[8] - AI-related revenue accounted for 15% of total revenue, an increase of 2.5 percentage points from 2024[9] Profitability and Margins - The company's gross profit margin was 46.8%, impacted by new capacity ramp-up, but improved by approximately 0.7 percentage points in Q4[9] Strategic Focus - The company is focusing on global market expansion and innovation, with new products launched including an automated tumor liquid robot and a high-speed centrifuge[10] Investment Risks - The company warns of investment risks as the financial data is preliminary and unaudited, with final figures to be disclosed in the annual report[13]

Financial Performance - In 2025, the company achieved total operating revenue of RMB 81,133.14 million, a year-on-year increase of 54.84%[4] - The net profit attributable to the parent company was a loss of RMB 22,667.02 million, narrowing the loss by 48.30% compared to the previous year[6] - The net profit attributable to the parent company, excluding non-recurring gains and losses, was a loss of RMB 32,031.65 million, narrowing the loss by 32.37% year-on-year[6] - The basic earnings per share were RMB -0.49, improving from RMB -0.96 in the previous year[4] - The weighted average return on net assets increased by 8.90 percentage points to -13.15%[4] Assets and Equity - The company's total assets at the end of the reporting period were RMB 194,795.44 million, a decrease of 11.92% from the beginning of the period[6] - The equity attributable to the parent company was RMB 164,290.22 million, down 9.05% from the beginning of the period[6] Business Focus and Growth Drivers - The company focused on core RF front-end chip business, driving revenue growth through product optimization and cost reduction[7] - The increase in operating revenue was significantly driven by the successful mass production of the Phase8L integrated L-PAMiD product in high-end Android flagship models[8] R&D and Government Support - Government subsidies related to revenue increased year-on-year, while R&D expenses decreased compared to the previous year[8]